0.00Open0.00Pre Close0 Volume0 Open Interest40.00Strike Price0.00Turnover0.00%IV83.99%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier17DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Biohaven Stock Discussion
Biohaven Announces Investment up to $600 Million by Oberland Capital
Biohaven (NYSE: BHVN) has secured a significant non-dilutive investment of up to $600 million from Oberland Capital Management The deal structure includes:
- $250 million to be funded at closing by April 30, 2025
- $150 million available upon achieving regulatory milestones for troriluzole
- Up to $200 million by mutual agreement for strategic acquisitions
The investment, structured as a Note Purchase Ag...
Biohaven's Next-Gen Neuroscience Pipeline: 13 Groundbreaking Studies Target Parkinson's and Migraine
Biohaven's Troriluzole Stuns with 70% SCA Progression Slowdown - FDA Priority Review Granted
Biohaven Achieves Positive Topline Results in Pivotal Study of Troriluzole in Spinocerebellar Ataxia (SCA)
• Troriluzole 200 mg dosed orally, once daily, in patients with SCA met the study's primary endpoint on the change from baseline in the modified functional Scale for the Assessment and Rating of Ataxia (f-SARA) at 3 years in all study population genotypes.
◦ Troriluzole also showed statistically significant superiority after both 1 and 2 years of treatment.
• Tror...
RBC upgrades Estee Lauder $Estee Lauder (EL.US)$ to outperform from sector perform
RBC said it sees an attractive risk/reward.
“We are upgrading EL shares to Outperform. At this point, we believe EPS and investor sentiment have troughed and believe the risk-to-reward profile skews favorable.”
Morgan Stanley reiterates Tesla $Tesla (TSLA.US)$ as overweight
Morgan Sta...
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings (CERE.US)$
$Amicus Therapeutics (FOLD.US)$
$Iovance Biotherapeutics (IOVA.US)$
$Arcellx (ACLX.US)$
$Nuvalent (NUVL.US)$
$Apogee Therapeutics (APGE.US)$
$Inhibrx (INBX.US)$
$Fusion Pharmaceuticals (FUSN.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Vaxcyte (PCVX.US)$
$Soleno Therapeutics (SLNO.US)$
$Medtronic (MDT.US)$
$Madrigal Pharmaceuticals (MDGL.US)$